Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor

During the past decades, immunotherapy, especially the antibody-mediated immune checkpoint blockade (ICB) has shown durable tumor inhibition and changed the paradigm of cancer treatment. However, a growing body of evidence suggests that ICB treatment induces severe immune-related adverse events (irA...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xin, Wang, Xueyan, Ma, Guozhen, Song, Jinen, Liu, Xiaowei, Wu, Xi, Zhao, Yujie, Liu, Xu, Liu, Zhihui, Zhang, Wei, Zhao, Xin, Zheng, Zirui, Jing, Jing, Shi, Hubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721049/
https://www.ncbi.nlm.nih.gov/pubmed/34987517
http://dx.doi.org/10.3389/fimmu.2021.793831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721049/
https://www.ncbi.nlm.nih.gov/pubmed/34987517
http://dx.doi.org/10.3389/fimmu.2021.793831

Ejemplares similares